
Use of a commercially available artificial tear product containing propylene glycol as a demulcent and phospholipids in a proprietary emulsion technology reduces tear evaporation for at least 60 minutes post-instillations in patients with aqueous deficient dry eye disease associated with a MGD.













































.png)


